About This Stock More About This StockReadReadReadRead
Article By: Rod Raynovich
Sunday, February 12, 2017 4:12 AM EST
We have updated the comparison of eight large cap biopharma stocks post 2016 earnings for the period ending 2/10/17. Keep in mind that in January 2016 there was a severe correction with stocks dropping 25-30% with lows being hit in February 2016.
Article By: Arpita Dutt
Thursday, February 2, 2017 8:56 AM EST
Companies like Celgene, Biogen and AbbVie reported fourth quarter results last week. Catabasis suffered a major setback with its lead pipeline candidate edasalonexent failing to meet the primary endpoint.